日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blood-based pre-screening in the SKYLINE secondary prevention Ph3 gantenerumab study

在 SKYLINE 二级预防 3 期 gantenerumab 研究中进行基于血液的预筛查

Bauer, Alina; Rabe, Christina; Schiffman, Courtney; Rose, Fiona; Respondek, Gesine; Gullotta, Fabiana; Schlieker, Laura; Jethwa, Alexander; Schrurs, Isabelle; Manuilova, Ekaterina; Ostrowitzki, Susanne; Bittner, Tobias

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

评估克雷尼珠单抗与安慰剂在早期阿尔茨海默病成人患者中的安全性和有效性:两项3期随机安慰剂对照试验

Ostrowitzki, Susanne; Bittner, Tobias; Sink, Kaycee M; Mackey, Howard; Rabe, Christina; Honig, Lawrence S; Cassetta, Emanuele; Woodward, Michael; Boada, Mercè; van Dyck, Christopher H; Grimmer, Timo; Selkoe, Dennis J; Schneider, Andres; Blondeau, Kathleen; Hu, Nan; Quartino, Angelica; Clayton, David; Dolton, Michael; Dang, Yifan; Ostaszewski, Beth; Sanabria-Bohórquez, Sandra M; Rabbia, Michael; Toth, Balazs; Eichenlaub, Udo; Smith, Jillian; Honigberg, Lee A; Doody, Rachelle S

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

一项评估普拉西珠单抗治疗早期帕金森病安全性和有效性的II期研究(PASADENA):研究原理、设计和基线数据

Pagano, Gennaro; Boess, Frank G; Taylor, Kirsten I; Ricci, Benedicte; Mollenhauer, Brit; Poewe, Werner; Boulay, Anne; Anzures-Cabrera, Judith; Vogt, Annamarie; Marchesi, Maddalena; Post, Anke; Nikolcheva, Tania; Kinney, Gene G; Zago, Wagner M; Ness, Daniel K; Svoboda, Hanno; Britschgi, Markus; Ostrowitzki, Susanne; Simuni, Tanya; Marek, Kenneth; Koller, Martin; Sevigny, Jeff; Doody, Rachelle; Fontoura, Paulo; Umbricht, Daniel; Bonni, Azad

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease

克雷尼珠单抗对轻度至中度阿尔茨海默病患者血浆和脑脊液β-淀粉样蛋白的药代动力学和药效学影响

Yoshida, Kenta; Moein, Anita; Bittner, Tobias; Ostrowitzki, Susanne; Lin, Helen; Honigberg, Lee; Jin, Jin Y; Quartino, Angelica

Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks

在接受剂量递增治疗长达 133 周的治疗中,克雷尼珠单抗治疗轻度至中度阿尔茨海默病患者的安全性、耐受性和药代动力学

Guthrie, Heather; Honig, Lawrence S; Lin, Helen; Sink, Kaycee M; Blondeau, Kathleen; Quartino, Angelica; Dolton, Michael; Carrasco-Triguero, Montserrat; Lian, Qinshu; Bittner, Tobias; Clayton, David; Smith, Jillian; Ostrowitzki, Susanne

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial

PRX002/RG7935(一种抗α-突触核蛋白单克隆抗体)多次递增剂量治疗帕金森病患者的安全性和耐受性:一项随机临床试验

Jankovic, Joseph; Goodman, Ira; Safirstein, Beth; Marmon, Tonya K; Schenk, Dale B; Koller, Martin; Zago, Wagner; Ness, Daniel K; Griffith, Sue G; Grundman, Michael; Soto, Jay; Ostrowitzki, Susanne; Boess, Frank G; Martin-Facklam, Meret; Quinn, Joseph F; Isaacson, Stuart H; Omidvar, Omid; Ellenbogen, Aaron; Kinney, Gene G

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting

全球多系统萎缩症研究路线图会议的建议

Walsh, Ryan R; Krismer, Florian; Galpern, Wendy R; Wenning, Gregor K; Low, Phillip A; Halliday, Glenda; Koroshetz, Walter J; Holton, Janice; Quinn, Niall P; Rascol, Olivier; Shaw, Leslie M; Eidelberg, David; Bower, Pam; Cummings, Jeffrey L; Abler, Victor; Biedenharn, Judy; Bitan, Gal; Brooks, David J; Brundin, Patrik; Fernandez, Hubert; Fortier, Philip; Freeman, Roy; Gasser, Thomas; Hewitt, Art; Höglinger, Günter U; Huentelman, Matt J; Jensen, Poul H; Jeromin, Andreas; Kang, Un Jung; Kaufmann, Horacio; Kellerman, Lawrence; Khurana, Vikram; Klockgether, Thomas; Kim, Woojin Scott; Langer, Carol; LeWitt, Peter; Masliah, Eliezer; Meissner, Wassilios; Melki, Ronald; Ostrowitzki, Susanne; Piantadosi, Steven; Poewe, Werner; Robertson, David; Roemer, Cyndi; Schenk, Dale; Schlossmacher, Michael; Schmahmann, Jeremy D; Seppi, Klaus; Shih, Lily; Siderowf, Andrew; Stebbins, Glenn T; Stefanova, Nadia; Tsuji, Shoji; Sutton, Sharon; Zhang, Jing

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

更正:一项针对阿尔茨海默病前驱期患者的gantenerumab III期随机试验

Ostrowitzki, Susanne; Lasser, Robert A; Dorflinger, Ernest; Scheltens, Philip; Barkhof, Frederik; Nikolcheva, Tania; Ashford, Elizabeth; Retout, Sylvie; Hofmann, Carsten; Delmar, Paul; Klein, Gregory; Andjelkovic, Mirjana; Dubois, Bruno; Boada, Mercè; Blennow, Kaj; Santarelli, Luca; Fontoura, Paulo

Characterization of 3 Novel Tau Radiopharmaceuticals, (11)C-RO-963, (11)C-RO-643, and (18)F-RO-948, in Healthy Controls and in Alzheimer Subjects

种新型 Tau 放射性药物 (11)C-RO-963、(11)C-RO-643 和 (18)F-RO-948 在健康对照和阿尔茨海默病受试者中的表征

Wong, Dean F; Comley, Robert A; Kuwabara, Hiroto; Rosenberg, Paul B; Resnick, Susan M; Ostrowitzki, Susanne; Vozzi, Cristina; Boess, Frank; Oh, Esther; Lyketsos, Constantine G; Honer, Michael; Gobbi, Luca; Klein, Gregory; George, Noble; Gapasin, Lorena; Kitzmiller, Kelly; Roberts, Josh; Sevigny, Jeff; Nandi, Ayon; Brasic, James; Mishra, Chakradhar; Thambisetty, Madhav; Mogekar, Abhay; Mathur, Anil; Albert, Marilyn; Dannals, Robert F; Borroni, Edilio

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers

在健康志愿者中首次对抗α-突触核蛋白单克隆抗体PRX002进行人体评估

Schenk, Dale B; Koller, Martin; Ness, Daniel K; Griffith, Sue G; Grundman, Michael; Zago, Wagner; Soto, Jay; Atiee, George; Ostrowitzki, Susanne; Kinney, Gene G